Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by CarbonWarrioron Nov 21, 2022 4:52pm
147 Views
Post# 35116855

RE:RE:RE:PR more partial responses form Adlay trial...

RE:RE:RE:PR more partial responses form Adlay trial...The one patient that got PR than progressed was going to not recover anyway, that patient was a lost cause... His life got extended nonetheless but we will never be able to measure it. 

The rest (89%) got their life extended for sure (either by SD or PR)... As they live on and on, this baby should grow.

Not sure why this company is not releasing a more aggressive news release...

Such as... We have demonstrated efficacy .... there are PR many PR and these folks are ALIVE. ALIVE I say. Zombie movie heavy metal music in the background. Then an explosion of money. Then a rainbow appears in the perfect blue sky signaling happiness for all (shareholders and cancer patients + their familey  (minus anyone shorting this stock)). 

What we got instead was a poster announcement at a nerdy conference that no one will attend... geeeeeez. You got to beat the drums here. To the very least put some promo girls here. OMG. Okay Okay, I am going back to mortgage the farm, the house, the cows, and the tractor on this one... Go  baby go!!!


<< Previous
Bullboard Posts
Next >>